Dynamic changes of soluble HLA-G and cytokine plasma levels in cervical cancer patients: potential role in cancer progression and immunotherapy.

Xu, Hui-Hui; Xie, You-You; Yang, Zhi; Han, Qiu-Yue

Xu, Hui-Hui; Xie, You-You; Yang, Zhi; Han, Qiu-Yue.

Afiliação

Xu HH; Medical Research Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, People's Republic of China. hui739@163.com.
Xie YY; Key Laboratory of Minimally Invasive Techniques and Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Linhai, Zhejiang, People's Republic of China. hui739@163.com.
Jun-Gan; Radiotherapy Department, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, People's Republic of China.
Yang Z; Medical Research Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, People's Republic of China.
Han QY; Medical Research Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, People's Republic of China.

J Cancer Res Clin Oncol ; 149(8): 4195-4204, 2023 Jul.

Article em En | MEDLINE | ID: mdl-36053326

Assuntos

Antígenos HLA-G; Neoplasias do Colo do Útero; Humanos; Feminino; Citocinas; Interleucina-10; Interleucina-17; Neoplasias do Colo do Útero/terapia; Interleucina-6; Interleucina-8; Imunoterapia; Microambiente Tumoral

Palavras-chave

Cervical cancer; Cytokine; Diagnosis; Immunotherapy; Inflammation; Soluble HLA-G

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Antígenos HLA-G Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de publicação: Alemanha

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google